N-[9-[(2R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-oxo-3H-purin-2-yl]-2-methylpropanamide
|
|
N-[9-[(2R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-oxo-3H-purin-2-yl]-2-methylpropanamide Eigenschaften
Sicherheit
N-[9-[(2R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-oxo-3H-purin-2-yl]-2-methylpropanamide Chemische Eigenschaften,Einsatz,Produktion Methoden
N-[9-[(2R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-oxo-3H-purin-2-yl]-2-methylpropanamide Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
N-[9-[(2R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-oxo-3H-purin-2-yl]-2-methylpropanamide Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 1)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
Wuhan Tangzhi Pharmaceutical Co., Ltd. | 0532-88500810 13658392159 |
sale@glycogene.com | China | 837 | 58 |
- N-[9-[(2R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-oxo-3H-purin-2-yl]-2-methylpropanamide
- N2-Isobutyryl-β-D-arabinofuranosylguanosine
- 199601-35-9